Machine Learning

Sanofi deepens its AI partnership with CytoReason in a $16M deal, signaling a major shift in using predictive models to accelerate immunology breakthroughs.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

The institutional crypto exchange reported a sharp decline in spot trading for December, but a massive surge in options volume points to a maturing market.

The acquisition combines autonomous ship platforms with advanced AI, creating an end-to-end solution aimed at dominating the future of maritime defense.

A new platform, ConvoGPT OS, has been unveiled with a bold mission: to eliminate human sales jobs, not just assist them, raising major questions for the future of work.

From a $2.3B real estate privatization to blockbuster retail earnings and a shifting job market, key corporate moves reveal a nation at a crossroads.

Kezar Life Sciences faces a critical FDA meeting for its novel liver disease drug, a decision that could bring hope to patients and define the company's future.

Laser tool maker Huepar validates its 5-year warranty with automated precision and plans a major service expansion in the UK, Europe, and the US.

Amid a major corporate restructure, Atos partners with the World DanceSport Federation, betting on tech to transform the ballroom and secure its market lead.

At AIMExpo 2026, ASMAX unveiled a rider-centric IoT ecosystem, aiming to redefine group communication and safety with advanced mesh and AI technology.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

A new report reveals shifting consumer demands for THCA flower, as the booming market grapples with quality standards and a complex regulatory future.

The smartphone giant joins the VVC Advance patent pool, a key move poised to speed up the adoption of next-gen video codecs for consumers worldwide.

Dr. Jill Tarter, the real-life inspiration for 'Contact,' wins the Green Sands Prize, validating her decades-long quest to legitimize the search for E.T.